Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Conditions
- Melanoma
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck
Interventions
- DRUG: brentuximab vedotin
- DRUG: pembrolizumab
Sponsor
Seagen, a wholly owned subsidiary of Pfizer
Collaborators